Aripiprazole is FDA approved for the acute and maintenance treatment of bipolar I disorder. Aripiprazole's efficacy during the long-term. Aripiprazole in the Maintenance Treatment of Bipolar Disorder: A Critical Review of the Evidence and Its Dissemination into the Scientific. L'aripiprazole, un agoniste partiel dopaminergique D2, réduit le «craving» mais pas la fréquence des prises. [6] Brown ES, Jeffress J, Liggin JD, Garza M, Beard L. Switching outpatients with bipolar or. Gabapentin maintenance decreases. augmentin 125 mg suspension new/9958-1-5155.php | ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|